Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

被引:1
|
作者
Goshua, George
Sinha, Pranay
Hendrickson, Jeanne E.
Tormey, Christopher A.
Bendapudi, Pavan
Lee, Alfred Ian
机构
关键词
D O I
10.1182/blood-2020-138515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Cost-Effectiveness of Caplacizumab in the Warranty Program in Immune Thrombotic Thrombocytopenic Purpura in the USA
    Sullivan, Sean D.
    Chaturvedi, Shruti
    Gautam, Preety
    Arnaud, Alix
    BLOOD, 2023, 142
  • [22] Caplacizumab for congenital thrombotic thrombocytopenic purpura
    Boothby, Aaron
    Mazepa, Marshall
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E420 - E421
  • [23] Caplacizumab in the Therapy of thrombotic thrombocytopenic Purpura
    Gappa, Birgit
    TRANSFUSIONSMEDIZIN, 2019, 9 (02) : 86 - +
  • [24] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Kaczmarek, Veronika
    Holle, Johannes
    Astudillo, Rebekka
    Kempf, Caroline
    Baler, Philip
    Mueller, Dominik
    PEDIATRIC NEPHROLOGY, 2019, 34 (09) : 1625 - 1628
  • [25] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Veronika Kaczmarek
    Johannes Holle
    Rebekka Astudillo
    Caroline Kempf
    Philip Bufler
    Dominik Müller
    Pediatric Nephrology, 2019, 34 : 1625 - 1628
  • [26] Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura
    Chander, Deepak P.
    Loch, Michelle M.
    Cataland, Spero R.
    George, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 92 - 94
  • [27] Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Hannah A. Blair
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 459 - 459
  • [28] Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
    del Rio-Garma, Julio
    Bobillo, Sabela
    de la Rubia, Javier
    Pascual, Cristina
    Garcia-Candel, Faustino
    Garcia-Gala, Jose M.
    Gonzalez, Reyes
    Abril, Laura
    Vidan, Julia
    Gomez, Maria Jesus
    Pena, Francisco
    Arbona, Cristina
    Martin-Sanchez, Jesus
    Moreno, Gemma
    Romon, Inigo
    Viejo, Aurora
    Oliva, Ana
    Linares, Monica
    Salinas, Ramon
    Perez, Sonia
    Garcia-Erce, Jose A.
    Pereira, Arturo
    ANNALS OF HEMATOLOGY, 2022, 101 (01) : 59 - 67
  • [29] Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
    Maqsood, Muhammad Haisum
    Rubab, Kinza
    Maqsood, Muhammad Zaigham
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [30] Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
    Julio del Río-Garma
    Sabela Bobillo
    Javier de la Rubia
    Cristina Pascual
    Faustino García-Candel
    Jose M. García-Gala
    Reyes Gonzalez
    Laura Abril
    Julia Vidan
    Maria Jesús Gomez
    Francisco Peña
    Cristina Arbona
    Jesús Martín-Sanchez
    Gemma Moreno
    Iñigo Romón
    Aurora Viejo
    Ana Oliva
    Mónica Linares
    Ramón Salinas
    Sonia Pérez
    Jose A. Garcia-Erce
    Arturo Pereira
    Annals of Hematology, 2022, 101 : 59 - 67